Skip to content
  • KOSPI 2556.61 -8.81 -0.34%
  • KOSDAQ 717.24 -9.22 -1.27%
  • KOSPI200 338.74 -0.32 -0.09%
  • USD/KRW 1438 1.00 -0.07%
View Market Snapshot
Bio & Pharma

Celltrion to acquire additional $72 mn in treasury shares

From November 22, the company's 583,431 shares will be repurchased on the market, bringing the total to $308 mn

By Nov 21, 2024 (Gmt+09:00)

1 Min read

Celltrion to acquire additional  mn in treasury shares 

South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).

From November 22, Celltrion plans to acquire 583,431 treasury shares through on-market purchases.

The company stated that this additional buyback is part of a shareholder-friendly policy to prioritize and enhance shareholder value.

The decision was made in response to the company's judgment that its corporate valuation has slowed, despite achieving record-breaking third-quarter sales and ongoing growth of its flagship products in global markets, along with approvals for new products.

Previously, Celltrion projected that its revenue for this year would reach a record high of 3.5 trillion won ($2.5 billion).

This marks the fifth share buyback by Celltrion this year, bringing the cumulative total for 2024 to 2,394,031 shares worth 430 billion won ($307.7 million).

Celltrion has consistently pursued shareholder value enhancement policies, including repurchasing 1,239 billion won ($886.5 million) worth of treasury shares last year.

This year, the company has also combined share buybacks with the cancellation of 700 billion won ($500.9 million) worth of treasury shares.

Write to Dae-Kyu Ahn at powerzanic@hankyung.com
More to Read
Comment 0
0/300